| Teva Pharmaceutical Industries Limited (TEVA) | |||
|---|---|---|---|
| 21.27 0.08 (0.38%) | 10-18 16:04 | ||
| Open: | 21.28 | Pre. Close: | 21.19 |
| High: | 21.88 | Low: | 21.135 |
| Volume: | 10,095,039 | Market Cap: | 21659M |
| Price Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 21.905 - 21.992 | 21.992 - 22.067 |
| Low: | 20.903 - 21.009 | 21.009 - 21.1 |
| Close: | 21.089 - 21.26 | 21.26 - 21.408 |
| Stock Technical Analysis | |
|---|---|
| Overall: |  |
| Target: | Six months: 27.20 One year: 29.35 |
| Support: | Support1: 20.31 Support2: 16.90 |
| Resistance: | Resistance1: 23.29 Resistance2: 25.13 |
| Pivot: | 21.45  |
| Moving Averages: | MA(5): 21.57 MA(20): 21.82  MA(100): 22.97 MA(250): 19.88 |
| MACD: | MACD(12,26): -0.39 Signal(12,26,9): -0.41 |
| %K %D: | %K(14,3): 53.02 %D(3): 48.30 |
| RSI: | RSI(14): 44.07 |
| 52-Week: | High: 25.96 Low: 10.85 Change(%): 42.8 |
| Average Vol(K): | 3-Month: 1244689 10-Days: 957938 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.TEVA has closed above bottom band by 38.7%. Bollinger Bands are 50% narrower than normal. The narrow width of the bands suggests low volatility as compared to TEVA's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend. |
| Stock chart |
|---|
 |
| Stock News |
|---|
|
2018-10-18T15:51:28-04:00 Corcept slips 3% on tentative FDA nod for Teva's generic mifepristone |
| Financial Analysis | |
|---|---|
| Growth |  |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
| Profitability |  |
| Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
| Solvency | |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
| Efficiency | |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. | |
| Stock Basics & Statistics | |
|---|---|
| Sector: Healthcare | |
| Industry: Drug Manufacturers - Specialty Generic | |
| Shares Out. (M) | 1018.28 |
| Shares Float (M) | 1015.86 |
| % Held by Insiders | 0.20 |
| % Held by Institutions | 67.40 |
| Shares Short (K) | 31799 |
| Shares Short Prior Month (K) | |
| Stock Financials | |
|---|---|
| EPS | 3.520 |
| EPS Est. Current Year | 4.230 |
| EPS Est. Next Year | 3.690 |
| EPS Est. Next Quarter | 1.090 |
| Forward EPS | 2.790 |
| Book Value (p.s.) | 1.510 |
| PEG Ratio | -0.98 |
| Profit Margin | -70.69 |
| Operating Margin | 16.65 |
| Return on Assets (ttm) | -13.4 |
| Return on Equity (ttm) | -53.2 |
| Qtrly Rev. Growth | -17.8 |
| Gross Profit (p.s.) | 5.092 |
| Sales Per Share | |
| EBITDA (p.s.) | -11.396 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | 4590.00 |
| Levered Free Cash Flow (M) | 2880.00 |
| Stock Valuation | |
|---|---|
| P/E | 6.04 |
| P/E Growth Ratio | |
| P/BV | 14.09 |
| P/S | 1061938368.00 |
| P/CF | 4.72 |
| Dividend Yield | 0.08 |
| Dividends & Splits | |
|---|---|
| Dividend | 1.634 |
| Dividend Pay Date | 2017-12-12 |
| Ex-Dividend Date | 2017-11-27 |
| Forward Dividend | |
| Last Split Date | |
| Last Split Ratio | -1e+010 |
